RE:CEO of Reliq's Competitor Talks About Covid ImpactIt is SHOCK and AWE strategy.
If we look at July to September 2020 of what we know:
2,000 patients signed in July 2020. If we assume $ 50 per month per patient then it comes to $ 100,000 per month or $ 1,200,000.
In August 2020 Lisa buys $ 50,000 of stock on the open market
THEREFORE,
I conclude that she is seeing something we are not.
I we assume regular 2,000 patient addition per month, then revenues will be 12 times higher in one year: 24,000 patients at $ 50 per month = $ 14,400,000.
Here we assume only 2,000 patients per month, if they are doing 10,000 patients per month, then we will will a ROARING stock price.
The fact that Trump and most of his team have covid19 will only serve to light a fire on the market in which Reliq is in, as now everyone is convinced that covid19 is real and is dangerous. The old people are going to be very fearful and not go to medical appointments, they want care from home.
MPO